Daily aspirin reduces risk of cancer

According to new research, long-term acceptance of low doses of aspirin significantly reduces the risk of various cancers.

In particular, researchers from Britain found evidence that low dose aspirin (75 milligrams) taken daily for at least five years by 10-60 percent (depending on the type of cancer) reduces the likelihood of cancer.
Results are based on fresh analysis of eight studies that involved more than 25,500 patients. These studies were conducted to study the effect of aspirin on cardiovascular disease.
However, the study's lead author, Professor Peter Rothwell of Oxford University says it does not mean that all adults should begin immediately to take aspirin.
Now recommended for healthy middle-aged people who have no risk of bleeding, to prevent cardiovascular disease.
The study's authors caution that further studies are needed to make recommendations on the use of aspirin for cancer prevention, but they suggest that greater benefit from taking aspirin 50-60 summer people.